V Craig Jordan

Summary

Affiliation: Georgetown University
Country: USA

Publications

  1. pmc The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities
    V Craig Jordan
    Lomhardi Comprehensive Cancer Center, Georgetown University, Washington, BC 20057, USA
    Breast 20:S1-11. 2011
  2. pmc The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice
    Philipp Y Maximov
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
    Curr Clin Pharmacol 8:135-55. 2013
  3. pmc Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis
    V Craig Jordan
    Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
    Cancer Prev Res (Phila) 4:633-7. 2011
  4. pmc Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines
    Ping Fan
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road NW, Washington, DC 20057, USA
    Eur J Cancer 48:3488-98. 2012
  5. pmc Progress in endocrine approaches to the treatment and prevention of breast cancer
    Ifeyinwa Obiorah
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, United States
    Maturitas 70:315-21. 2011
  6. pmc c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells
    Ping Fan
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA
    Cancer Res 73:4510-20. 2013
  7. doi request reprint Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story
    Russell E McDaniel
    Department of Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA
    Vitam Horm 93:1-49. 2013
  8. pmc Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality
    Ifeyinwa Obiorah
    From the Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center, Washington, DC
    Menopause 20:372-82. 2013

Collaborators

  • Russell E McDaniel
  • Ping Fan
  • Ifeyinwa Obiorah
  • Philipp Y Maximov
  • Karen Creswell
  • Xiaojun Zou
  • Obi L Griffith
  • Joe W Gray
  • Fadeke A Agboke
  • Sung Hoon Kim
  • Pavana Anur
  • John A Katzenellenbogen
  • Theresa M Lee
  • Bassem Haddad
  • Helen R Kim
  • Dionyssia Clagett

Detail Information

Publications8

  1. pmc The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities
    V Craig Jordan
    Lomhardi Comprehensive Cancer Center, Georgetown University, Washington, BC 20057, USA
    Breast 20:S1-11. 2011
    ....
  2. pmc The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice
    Philipp Y Maximov
    Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
    Curr Clin Pharmacol 8:135-55. 2013
    ..In this article, we describe the discovery and development of the group of medicines called SERMs. The newer SERMs in late development: ospemifene, lasofoxifene, bazedoxifene, are arzoxifene are described in detail...
  3. pmc Paradoxical clinical effect of estrogen on breast cancer risk: a "new" biology of estrogen-induced apoptosis
    V Craig Jordan
    Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, USA
    Cancer Prev Res (Phila) 4:633-7. 2011
    ..Cell populations emerge with a vulnerability, as estrogen is no longer a survival signal but is an apoptotic trigger. The antitumor effect of ERT in estrogen-deprived postmenopausal women is consistent with laboratory models...
  4. pmc Modulating therapeutic effects of the c-Src inhibitor via oestrogen receptor and human epidermal growth factor receptor 2 in breast cancer cell lines
    Ping Fan
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, 3970 Reservoir Road NW, Washington, DC 20057, USA
    Eur J Cancer 48:3488-98. 2012
    ..A specific c-Src inhibitor, 4-amino-5-(4-chlorophenyl)-7(t-butyl)pyrazolo[3,4-d]pyrinidine (PP2), was utilised to block c-Src activity to identify targeted vulnerabilities affected by ER and HER2 in a panel of breast cancer cell lines...
  5. pmc Progress in endocrine approaches to the treatment and prevention of breast cancer
    Ifeyinwa Obiorah
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC 20057, United States
    Maturitas 70:315-21. 2011
    ..This review outlines the current strategies employed in the use of endocrine therapy in the management and prevention of breast cancer...
  6. pmc c-Src modulates estrogen-induced stress and apoptosis in estrogen-deprived breast cancer cells
    Ping Fan
    Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA
    Cancer Res 73:4510-20. 2013
    ..This work offers a mechanistic rationale for a new approach in the treatment of endocrine-resistant breast cancer...
  7. doi request reprint Estrogen-mediated mechanisms to control the growth and apoptosis of breast cancer cells: a translational research success story
    Russell E McDaniel
    Department of Oncology, Georgetown University, Lombardi Comprehensive Cancer Center, Washington, District of Columbia, USA
    Vitam Horm 93:1-49. 2013
    ....
  8. pmc Scientific rationale for postmenopause delay in the use of conjugated equine estrogens among postmenopausal women that causes reduction in breast cancer incidence and mortality
    Ifeyinwa Obiorah
    From the Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University Medical Center, Washington, DC
    Menopause 20:372-82. 2013
    ..These nascent tumors are now vulnerable to estrogen-induced apoptosis. ..